{
    "nct_id": "NCT03538951",
    "official_title": "Phase 2B Open-Label Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis",
    "inclusion_criteria": "* 4-8 grade 1 or grade 2 AK lesions in Treatment Field on face or scalp\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Subject has no clinically significant findings at Baseline\n* Subject is unable to demonstrate adequate precision applying the study drug to the Treatment Field at Baseline\n* Subject has in the opinion of the Investigator (a) an unstable medical, psychiatric, social problem\n* Subject has at any time been given a diagnosis or treatment associated with immunosuppression\n* Subject has received VDA-1102 in the past",
    "miscellaneous_criteria": ""
}